Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Prelude Therapeutics Incorporated (PRLD) had Pre-Tax Income of $-31.23M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-31.23M |
|
-- |
|
-- |
|
$32.19M |
|
$-32.19M |
|
$0.96M |
|
|
Pre-Tax Income |
$-31.23M |
$-31.23M |
|
$-31.23M |
|
$-31.23M |
|
$-31.23M |
|
$-31.23M |
|
$-32.19M |
|
$-31.97M |
|
75.99M |
|
75.99M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$76.88M |
|
$5.96M |
|
$38.04M |
|
$114.92M |
|
$20.91M |
|
-- |
|
$18.17M |
|
$39.08M |
|
$75.84M |
|
$75.84M |
|
$75.84M |
|
56.59M |
|
| Cash Flow Statement Financials | |
$-60.31M |
|
$73.71M |
|
$-0.12M |
|
$16.52M |
|
$29.80M |
|
$13.28M |
|
$7.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-60.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-41.18% |
|
-41.18% |
|
-27.18% |
|
-41.18% |
|
$1.34 |
|
$-0.79 |
|
$-0.79 |
|